Silence Therapeutics News

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 2 04:42

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 29 20:38

Silence Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 15 19:03

Silence Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Ian Griffiths(16.9%),Ora Capital Limited(7.8%)

Mar 28 05:10

Silence Therapeutics | 20-F: Registration statement / Annual report / Transition report

Mar 13 20:58

Silence Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 13 19:13

Silence Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 23 21:14

Silence Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lombard Odier Asset Management (USA) Corp(10.4%)

Feb 14 22:57

Silence Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(5.43%),Deep Track Biotechnology Master Fund, Ltd.(5.43%), etc.

Feb 14 21:57

Silence Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(2.2 %),GOLDMAN SACHS & CO. LLC(2.2 %)

Feb 13 07:20

Silence Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(7.8%),Invus Public Equities Advisors, LLC(7.8%), etc.

Feb 10 06:10

Silence Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 7 02:57

Silence Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 1, 2023 20:00

Silence Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 14, 2023 20:00

Silence Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Nov 1, 2023 19:00

Silence Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Invus Public Equities, L.P.(6.8%),Invus Public Equities Advisors, LLC(6.8%), etc.

Sep 2, 2023 04:12

Silence Therapeutics | 6-K/A: Report of foreign private issuer (related to financial reporting)

Aug 30, 2023 04:01

Silence Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 16, 2023 19:00

Silence Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Ian Griffiths(26.58%)

Aug 15, 2023 05:01

Silence Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 2, 2023 04:31